- Home
- CCEL vs VSTD Comparison
CCEL vs VSTD Comparison
Compare CCEL & VSTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- VSTD
- Stock Information
- Founded
- CCEL 1989
- VSTD 2016
- Country
- CCEL United States
- VSTD United States
- Employees
- CCEL N/A
- VSTD N/A
- Industry
- CCEL Managed Health Care
- VSTD Restaurants
- Sector
- CCEL Health Care
- VSTD Consumer Discretionary
- Exchange
- CCEL Nasdaq
- VSTD Nasdaq
- Market Cap
- CCEL 34.8M
- VSTD 30.3M
- IPO Year
- CCEL 1997
- VSTD 2022
- Fundamental
- Price
- CCEL $4.44
- VSTD N/A
- Analyst Decision
- CCEL Strong Buy
- VSTD
- Analyst Count
- CCEL 1
- VSTD 0
- Target Price
- CCEL $8.50
- VSTD N/A
- AVG Volume (30 Days)
- CCEL 27.1K
- VSTD 3.9M
- Earning Date
- CCEL 10-14-2025
- VSTD 08-20-2025
- Dividend Yield
- CCEL 13.27%
- VSTD N/A
- EPS Growth
- CCEL N/A
- VSTD N/A
- EPS
- CCEL N/A
- VSTD N/A
- Revenue
- CCEL $31,988,783.00
- VSTD $13,902,861.00
- Revenue This Year
- CCEL $1.75
- VSTD N/A
- Revenue Next Year
- CCEL N/A
- VSTD N/A
- P/E Ratio
- CCEL N/A
- VSTD N/A
- Revenue Growth
- CCEL 1.10
- VSTD 30.39
- 52 Week Low
- CCEL $4.09
- VSTD $0.68
- 52 Week High
- CCEL $9.43
- VSTD $5.63
- Technical
- Relative Strength Index (RSI)
- CCEL 45.46
- VSTD N/A
- Support Level
- CCEL $4.20
- VSTD N/A
- Resistance Level
- CCEL $4.70
- VSTD N/A
- Average True Range (ATR)
- CCEL 0.20
- VSTD 0.00
- MACD
- CCEL 0.01
- VSTD 0.00
- Stochastic Oscillator
- CCEL 38.71
- VSTD 0.00
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.